Interest  	Interest  	 NN	O
of  	of  	 IN	O
NT-proBNP  	NT-proBNP  	 JJ	B-NP
in  	in  	 IN	O
chronic  	chronic  	 JJ	B-NP
heart  	heart  	 NN	I-NP
failure  	failure  	 NN	I-NP
follow-up  	follow-up  	 NN	I-NP
Reducing  	Reducing  	 VBG	I-NP
readmissions  	readmissions  	 NN	I-NP
after  	after  	 IN	O
hospitalisation  	hospitalisation  	 NN	B-NP
for  	for  	 IN	O
acute  	acute  	 JJ	O
heart  	heart  	 NN	B-NP
failure  	failure  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
new  	new  	 JJ	O
challenge  	challenge  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
diseases 	diseases 	 NNS	O
,  	,  	 ,	O
approaching  	approaching  	 VBG	O
30 	30 	 CD	O
%  	%  	 NN	O
within  	within  	 IN	O
60  	60  	 CD	O
to  	to  	 TO	O
90  	90  	 CD	O
days  	days  	 NNS	O
of  	of  	 IN	O
discharge 	discharge 	 NN	O
.  	.  	 .	O
Congestion  	Congestion  	 RB	B-NP
related  	related  	 VBN	O
to  	to  	 TO	O
high  	high  	 JJ	O
ventricular  	ventricular  	 NNS	O
filling  	filling  	 VBG	B-NP
pressures 	pressures 	 NNS	I-NP
,  	,  	 ,	O
reflected  	reflected  	 VBD	O
by  	by  	 IN	O
the  	the  	 DT	O
high  	high  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
natriuretic  	natriuretic  	 JJ	B-NP
peptides 	peptides 	 NN	I-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
the  	the  	 DT	O
main  	main  	 JJ	O
reason  	reason  	 NN	O
for  	for  	 IN	O
heart  	heart  	 NN	B-NP
failure  	failure  	 NN	I-NP
readmission 	readmission 	 NN	I-NP
.  	.  	 .	O
Natriuretic  	Natriuretic  	 JJ	B-NP
peptide  	peptide  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
are  	are  	 VBP	O
a  	a  	 DT	O
patent  	patent  	 NN	O
prognostic  	prognostic  	 NN	B-NP
marker  	marker  	 NN	I-NP
of  	of  	 IN	I-NP
cardiovascular  	cardiovascular  	 JJ	I-NP
event  	event  	 NN	I-NP
in  	in  	 IN	O
chronic  	chronic  	 JJ	B-NP
heart  	heart  	 NN	I-NP
failure 	failure 	 NN	I-NP
.  	.  	 .	O
Treshold  	Treshold  	 JJ	B-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
BNP  	BNP  	 NNP	B-NP
and  	and  	 CC	O
NT-proBNP  	NT-proBNP  	 JJ	B-NP
being  	being  	 VBG	O
respectively  	respectively  	 RB	O
125  	125  	 CD	O
and  	and  	 CC	O
1000  	1000  	 CD	O
pg 	pg 	 CD	B-NP
/ 	/ 	 CD	I-NP
mL 	mL 	 NN	I-NP
.  	.  	 .	O
Optimizing  	Optimizing  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
of  	of  	 IN	I-NP
heart  	heart  	 NN	I-NP
failure  	failure  	 NN	I-NP
by  	by  	 IN	O
monitoring  	monitoring  	 VBG	O
natriuretic  	natriuretic  	 JJ	B-NP
peptides 	peptides 	 NN	I-NP
,  	,  	 ,	O
including  	including  	 VBG	B-NP
management  	management  	 NN	I-NP
of  	of  	 IN	I-NP
diuretic  	diuretic  	 JJ	I-NP
doses 	doses 	 NNS	I-NP
,  	,  	 ,	O
remains  	remains  	 VBZ	O
matter  	matter  	 NN	O
of  	of  	 IN	O
controversies 	controversies 	 NNS	O
.  	.  	 .	O
